Severe cytokine release syndrome after the first dose of Brentuximab Vedotin in a patient with relapsed systemic anaplastic large cell lymphoma (sALCL): a case report and review of literature.
Saved in:
| Title: | Severe cytokine release syndrome after the first dose of Brentuximab Vedotin in a patient with relapsed systemic anaplastic large cell lymphoma (sALCL): a case report and review of literature. |
|---|---|
| Authors: | Alig SK; Department of Medicine III, Medical Centre of the University of Munich, Munich, Germany., Dreyling M; Department of Medicine III, Medical Centre of the University of Munich, Munich, Germany., Seppi B; Department of Medicine III, Medical Centre of the University of Munich, Munich, Germany., Aulinger B; Department of Medicine II, Medical Centre of the University of Munich, Munich, Germany., Witkowski L; Department of Medicine III, Medical Centre of the University of Munich, Munich, Germany., Rieger CT; Department of Medicine III, Medical Centre of the University of Munich, Munich, Germany. |
| Source: | European journal of haematology [Eur J Haematol] 2015 Jun; Vol. 94 (6), pp. 554-7. Date of Electronic Publication: 2014 Jul 02. |
| Publication Type: | Case Reports; Journal Article; Review |
| Journal Info: | Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
